Logo

Japan's NCRI Uses Nonlinear Dynamics' Proteomics Software in Biomarker Hunt

Oct 04, 2007
NEW YORK (GenomeWeb News) - Japan's National Cancer Research Institute is using Nonlinear Dynamics' 2D gel analysis software in research aimed at discovering and validating biomarkers for cancer diagnostics, the company said today.
 
The NCRI is using the company’s Progenesis SameSpots image analysis platform to develop biomarker candidates that would predict response to the cancer therapy gefitinib in lung adenocarcinoma. The project is also planning to identify markers that will predict a patient's risk of cancer recurrence, the company said.
 
The NCRI’s clinical proteomics group currently runs more than 1,500 2D-DIGE gels per year.
 
Financial terms of the agreement were not released.

Breaking News
The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.